Bayer launches endometriosis awareness campaign; Leo introduces psoriasis treatment Otrexup; Sanofi rolls out online midwife community;

> Bayer HealthCare teamed up with Latifah Hospital in the United Arab Emirates on an endometriosis awareness campaign. Report

> Leo Pharma rolled out its new psoriasis drug Otrexup, a subcutaneous formula of methotrexate developed with Antares Pharma, in the U.S. Release

> Sanofi ($SNY) launches a new online community, Connecting Midwives, in cooperation with the International Confederation of Midwives; it follows up on the company's Connecting Nurses site. Report

> The healthcare agency Draftfcb Healthcare changed its name to FCB Health and bought the U.K. healthcare agency Halesway. Report

> Bayer Canada won approval for the new pulmonary arterial hypertension treatment, Adempas, from Health Canada. Report

> Pivotal Therapeutics recruited James Connolly, a former Wyeth executive, to serve on its board and advise the company on commercialization strategies. Report

> Teva Pharmaceutical Industries ($TEVA) rolled out its version of Roche's ($RHHBY) cancer treatment Xeloda in the U.S. Release

And Finally... How did Merck ($MRK) roll out a digital marketing strategy in the virgin territory of Indonesia? Report

Suggested Articles

Move over, Roche. There’s a new small-cell lung cancer therapy on the scene, and it belongs to AstraZeneca.

Gilead CEO promised to make remdesivir affordable, shortly after the company backed off its request for orphan status amid a public backlash.

Weeks after launching a U.S. trial to evaluate IL-6 inhibitor Kevzara for COVID-19, Sanofi and Regeneron have launched a matching study abroad.